Eli Lilly & Co. (NYSE:LLY)

CAPS Rating: 4 out of 5

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.

Recs

0
Player Avatar Kimer62 (34.18) Submitted: 11/29/2012 8:16:00 PM : Outperform Start Price: $47.60 LLY Score: -0.17

Value and dividend

Featured Broker Partners


Advertisement